<DOC>
	<DOCNO>NCT01447667</DOCNO>
	<brief_summary>The purpose study determine : - The efficacy MRE score predictor HCC recurrence within 2 year RFA treatment - The efficacy indicator ( MRE score , non-invasive serum marker ) compare gold-standard histology score predict hepatic fibrosis</brief_summary>
	<brief_title>Magnetic Resonance Elastography ( MRE ) Predictor HCC Recurrence After Radiofrequency Ablation ( RFA )</brief_title>
	<detailed_description>To evaluate whether MRE score reflect hepatic fibrosis predict recurrence HCC within 2 year RFA treatment - Local recurrence/intrahepatic distant recurrence - Multivariable analysis include several related factor find whether MRE score independent predictor HCC recurrence even adjust factor ( etiology liver disease , size HCC , vessel invasion , HBsAg titer , etc . ) To find efficacy indicator ( MRE score , non-invasive serum marker ) compare gold-standard histology score predict hepatic fibrosis .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Diagnosed single hypervascular hepatocellular carcinoma initially AJCC stage I HCC ChildPugh class A Planning radiofrequency ablation HCC Voluntary agreement study Decreased kidney function ( GFR &lt; 70 mL/min/kg ) Contraindication MRI ( pacemaker , defibrillator ) Contrast medium hypersensitivity Other primary malignancy Acute viral hepatitis Prior history liver transplantation Thrombosis splenic vein portal vein Patients enrol clinical trial within 4 week Other severe chronic disease psychiatric disease Pregnant milkfeeding woman Patients coagulopathy , high risk bleed liver biopsy Patients disagree participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Hepatic fibrosis</keyword>
	<keyword>Magnetic resonance elastography</keyword>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Recurrence</keyword>
</DOC>